TALPHERA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
TALPHERA, INC. (TLPH) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-06.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2024-03-06
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $0.00.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $0.00.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2019 was $100.00K, a 50.00% decline from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 90 month |
|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-06 | ||
| 2022-12-31 | $0.00 10-K · filed 2024-03-06 | ||
| 2021-12-31 | $5.70K 8-K · filed 2023-08-01 | $5.70M 10-K · filed 2022-03-10 | |
| 2020-12-31 | $0.00 10-K · filed 2022-03-10 | ||
| 2019-12-31 | $100.00K 10-K · filed 2021-03-15 | ||
| 2018-12-31 | $200.00K 10-K · filed 2021-03-15 | ||
| 2017-12-31 | $40.00K 10-K · filed 2020-03-16 | ||
| 2016-12-31 | $0.00 10-K · filed 2019-03-07 | ||
| 2015-12-31 | $1.30M 10-K · filed 2018-03-09 | ||
| 2014-12-31 | $2.30M 10-K · filed 2017-03-03 | ||
| 2013-12-31 | $3.60M 10-K · filed 2016-03-07 | ||
| 2012-12-31 | $85.00K 10-K · filed 2015-03-13 | $354.00K 10-K · filed 2013-03-12 | |
| 2011-12-31 | $204.00K 10-K · filed 2014-03-17 | ||
| 2010-12-31 | $3.00K 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |